{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:44:10Z","timestamp":1792100650807,"version":"4.4.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR160023"],"award-info":[{"award-number":["RR160023"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck & Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016256","name":"College of Natural Sciences, University of Texas at Austin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.celrep.2026.117936","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:08:27Z","timestamp":1788898107000},"page":"117936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structure-based design of soluble prefusion-stabilized herpes simplex virus type 2 glycoprotein B antigens"],"prefix":"10.1016","volume":"45","author":[{"given":"Madeline R.","family":"Sponholtz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne Y.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9112-9402","authenticated-orcid":false,"given":"Emmanuel","family":"Ndashimye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick O.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithya","family":"Thambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"McCool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Slein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole V.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"2nd","given":"William A.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Durr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3991-542X","authenticated-orcid":false,"given":"Jason S.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.117936_bib1","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001673","article-title":"ICTV Virus Taxonomy Profile: Herpesviridae 2021","volume":"102","author":"Gatherer","year":"2021","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.celrep.2026.117936_bib2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/sextrans-2024-056307","article-title":"Estimated global and regional incidence and prevalence of herpes simplex virus infections and genital ulcer disease in 2020: mathematical modelling analyses","volume":"101","author":"Harfouche","year":"2025","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.celrep.2026.117936_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.aids.0000198081.09337.a7","article-title":"Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies","volume":"20","author":"Freeman","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.celrep.2026.117936_bib4","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.clinthera.2018.07.006","article-title":"Antiviral Therapies for Herpesviruses: Current Agents and New Directions","volume":"40","author":"Poole","year":"2018","journal-title":"Clin. Ther."},{"key":"10.1016\/j.celrep.2026.117936_bib5","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/sextrans-2011-050099","article-title":"Herpes simplex virus type 2 serological testing and psychosocial harm: a systematic review","volume":"87","author":"Ross","year":"2011","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.celrep.2026.117936_bib6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/13872877251317228","article-title":"Increased risk of dementia associated with herpes simplex virus infections: Evidence from a retrospective cohort study using U.S. electronic health records","volume":"104","author":"Araya","year":"2025","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.celrep.2026.117936_bib7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41579-020-00448-w","article-title":"The structural basis of herpesvirus entry","volume":"19","author":"Connolly","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.celrep.2026.117936_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1126548","article-title":"Crystal structure of glycoprotein B from herpes simplex virus 1","volume":"313","author":"Heldwein","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117936_bib9","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1016\/j.celrep.2020.03.025","article-title":"Structure-Based Design of Prefusion-Stabilized Filovirus Glycoprotein Trimers","volume":"30","author":"Rutten","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117936_bib10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3389\/fimmu.2020.00842","article-title":"Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development","volume":"11","author":"Loomis","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2026.117936_bib11","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117936_bib12","doi-asserted-by":"crossref","first-page":"12265","DOI":"10.1073\/pnas.1811980115","article-title":"Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4","volume":"115","author":"Stewart-Jones","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117936_bib13","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117936_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade6422","article-title":"Rational design of a highly immunogenic prefusion-stabilized F glycoprotein antigen for a respiratory syncytial virus vaccine","volume":"15","author":"Che","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2026.117936_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev-med-121217-094234","article-title":"Structure-Based Vaccine Antigen Design","volume":"70","author":"Graham","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.celrep.2026.117936_bib16","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2404250121","article-title":"Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation","volume":"121","author":"Sponholtz","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117936_bib17","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41467-025-67969-x","article-title":"Structure and immunogenicity of an engineered soluble prefusion-stabilized EBV gB antigen","volume":"17","author":"McCool","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117936_bib18","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1038\/s41564-025-02153-x","article-title":"Prefusion structure, evasion and neutralization of HSV-1 glycoprotein B","volume":"10","author":"Roark","year":"2025","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.celrep.2026.117936_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000150219","article-title":"Different mechanisms of protection by monoclonal and polyclonal antibodies during the course of herpes simplex virus infection","volume":"32","author":"Eis-H\u00fcbinger","year":"1991","journal-title":"Intervirology"},{"key":"10.1016\/j.celrep.2026.117936_bib20","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1128\/JVI.01924-10","article-title":"Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus","volume":"85","author":"Krawczyk","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117936_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.hlife.2023.12.004","article-title":"The structure of HSV-1 gB bound to a potent neutralizing antibody reveals a conservative antigenic domain across herpesviruses","volume":"2","author":"Sun","year":"2024","journal-title":"hLife"},{"key":"10.1016\/j.celrep.2026.117936_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161968","article-title":"A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice","volume":"133","author":"Kuraoka","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2026.117936_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12929-024-01045-2","article-title":"Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus","volume":"31","author":"Seyfizadeh","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.celrep.2026.117936_bib24","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117936_bib25","article-title":"Prefusion structure of human cytomegalovirus glycoprotein B and structural basis for membrane fusion","volume":"7","author":"Liu","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2026.117936_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102209","article-title":"Principles and practical applications of structure-based vaccine design","volume":"77","author":"Byrne","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.celrep.2026.117936_bib27","doi-asserted-by":"crossref","first-page":"8176","DOI":"10.1038\/ncomms9176","article-title":"Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody","volume":"6","author":"Chandramouli","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117936_bib28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41586-025-09438-5","article-title":"A nanobody specific to prefusion glycoprotein B neutralizes HSV-1 and HSV-2","volume":"646","author":"Vollmer","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117936_bib29","article-title":"Computational design of prefusion-stabilized Herpesvirus gB trimers","volume":"2024","author":"McCallum","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2026.117936_bib30","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/s41467-019-09807-5","article-title":"Transient opening of trimeric prefusion RSV F proteins","volume":"10","author":"Gilman","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117936_bib31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41594-022-00735-5","article-title":"The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing novel epitopes","volume":"29","author":"Costello","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2026.117936_bib32","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2019.03.048","article-title":"Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism","volume":"177","author":"Watanabe","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117936_bib33","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.cell.2019.04.011","article-title":"A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface","volume":"177","author":"Bangaru","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117936_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12350","article-title":"Mouse and human FcR effector functions","volume":"268","author":"Bruhns","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.celrep.2026.117936_bib35","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1073\/pnas.74.9.3913","article-title":"Cell fusion induced by herpes simplex virus is promoted and suppressed by different viral glycoproteins","volume":"74","author":"Manservigi","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117936_bib36","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1128\/jvi.62.8.2596-2604.1988","article-title":"Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion","volume":"62","author":"Cai","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117936_bib37","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0042-6822(86)90196-0","article-title":"The nucleotide sequence of the gB glycoprotein gene of HSV-2 and comparison with the corresponding gene of HSV-1","volume":"155","author":"Bzik","year":"1986","journal-title":"Virology"},{"key":"10.1016\/j.celrep.2026.117936_bib38","doi-asserted-by":"crossref","first-page":"9213","DOI":"10.1128\/JVI.01213-15","article-title":"Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific","volume":"89","author":"Cairns","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117936_bib39","doi-asserted-by":"crossref","first-page":"12612","DOI":"10.1128\/JVI.01930-14","article-title":"Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans","volume":"88","author":"Cairns","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117936_bib40","article-title":"Effector functions are required for broad and potent protection of neonatal mice with antibodies targeting HSV glycoprotein D","volume":"5","author":"Slein","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2026.117936_bib41","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88529","article-title":"HSV-2 DeltagD elicits FcgammaR-effector antibodies that protect against clinical isolates","volume":"1","author":"Petro","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.celrep.2026.117936_bib42","doi-asserted-by":"crossref","first-page":"S950","DOI":"10.1093\/clind\/13.Supplement_11.S950","article-title":"Role of antibody-dependent cellular cytotoxicity in neonatal infection with herpes simplex virus","volume":"13","author":"Kohl","year":"1991","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.celrep.2026.117936_bib43","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/infdis\/160.5.770","article-title":"Neonatal antibody-dependent cellular cytotoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection","volume":"160","author":"Kohl","year":"1989","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.celrep.2026.117936_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00050-26","article-title":"Antibodies targeting HSV glycoprotein B require effector functions to protect neonatal mice","volume":"100","author":"Slein","year":"2026","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117936_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw7083","article-title":"Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes","volume":"4","author":"Awasthi","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2026.117936_bib46","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152310","article-title":"Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models","volume":"131","author":"Awasthi","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2026.117936_bib47","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41541-023-00684-0","article-title":"Analyzing immune responses to varied mRNA and protein vaccine sequences","volume":"8","author":"Park","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.celrep.2026.117936_bib48","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.282.4.331","article-title":"Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group","volume":"282","author":"Corey","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.celrep.2026.117936_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007452","article-title":"Different functional states of fusion protein gB revealed on human cytomegalovirus by cryo electron tomography with Volta phase plate","volume":"14","author":"Si","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2026.117936_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.02178-24","article-title":"A human cytomegalovirus prefusion-like glycoprotein B subunit vaccine elicits humoral immunity similar to that of postfusion gB in mice","volume":"99","author":"Karthigeyan","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117936_bib51","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2026.117936_bib52","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-024-07215-4","article-title":"Automated model building and protein identification in cryo-EM maps","volume":"628","author":"Jamali","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117936_bib53","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.celrep.2026.117936_bib54","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2026.117936_bib55","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1107\/S2059798318002425","article-title":"ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps","volume":"74","author":"Croll","year":"2018","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.celrep.2026.117936_bib56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: Structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.celrep.2026.117936_bib57","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","article-title":"Automated electron microscope tomography using robust prediction of specimen movements","volume":"152","author":"Mastronarde","year":"2005","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.celrep.2026.117936_bib58","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.celrep.2026.117936_bib59","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.vaccine.2015.10.132","article-title":"A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens","volume":"34","author":"Swaminathan","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2026.117936_bib60","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/bioinformatics\/btp163","article-title":"Biopython: freely available Python tools for computational molecular biology and bioinformatics","volume":"25","author":"Cock","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2026.117936_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080635","article-title":"Maximum allowed solvent accessibilites of residues in proteins","volume":"8","author":"Tien","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2026.117936_bib62","doi-asserted-by":"crossref","first-page":"279","DOI":"10.21105\/joss.00279","article-title":"BioPandas: Working with molecular structures in pandas DataFrames","volume":"2","author":"Raschka","year":"2017","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.celrep.2026.117936_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007095","article-title":"Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs","volume":"14","author":"Hook","year":"2018","journal-title":"PLoS Pathog."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726010144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726010144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:50:26Z","timestamp":1792097426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726010144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2211124726010144"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117936","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-based design of soluble prefusion-stabilized herpes simplex virus type 2 glycoprotein B antigens","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117936"}}